↓ Skip to main content

Dove Medical Press

Article Metrics

Review of teriflunomide and its potential in the treatment of multiple sclerosis

Overview of attention for article published in Neuropsychiatric Disease and Treatment, May 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

patent
9 patents
wikipedia
1 Wikipedia page

Citations

dimensions_citation
63 Dimensions

Readers on

mendeley
95 Mendeley
Title
Review of teriflunomide and its potential in the treatment of multiple sclerosis
Published in
Neuropsychiatric Disease and Treatment, May 2009
DOI 10.2147/ndt.s4474
Authors

Bernd Kieseier

Mendeley readers

The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Spain 1 1%
United States 1 1%
Unknown 92 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 16%
Student > Bachelor 10 11%
Student > Ph. D. Student 10 11%
Student > Doctoral Student 10 11%
Other 7 7%
Other 25 26%
Unknown 18 19%
Readers by discipline Count As %
Medicine and Dentistry 32 34%
Agricultural and Biological Sciences 14 15%
Neuroscience 5 5%
Biochemistry, Genetics and Molecular Biology 4 4%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Other 16 17%
Unknown 20 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 March 2020.
All research outputs
#1,564,663
of 18,313,653 outputs
Outputs from Neuropsychiatric Disease and Treatment
#197
of 2,720 outputs
Outputs of similar age
#39,802
of 289,031 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#2
of 79 outputs
Altmetric has tracked 18,313,653 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,720 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 289,031 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 79 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.